Bicara Therapeutics Inc. BCAX
19.21
(0.57)
(2.88%)
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 0.0×
Follow BCAX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
14.14 | 14.58 | 13.85 | 11.59 |
Net Debt/EBITDA |
7.14 | 10.16 | 9.02 | 8.33 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.81 | 0.64 | 0.67 | 0.80 | |
Capex/Depreciation |
(0.75) | (0.76) | (0.16) | (0.21) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.54) | (0.44) | (0.62) | (0.65) | |
Cash per Share |
5.32 | 7.59 | 8.89 | 7.32 | |
Shareholders Equity per Share |
7.38 | 7.34 | 8.46 | 6.90 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.38 | 7.34 | 8.46 | 6.90 | |
Free Cash Flow |
(29.29) | (24.12) | (37.57) | (44.27) | |
Working Capital |
276.34 | 393.10 | 505.58 | 460.35 | |
Capital Expenditures |
(0.04) | (0.24) | (0.06) | (0.06) | |
Net Current Asset Value |
275.46 | 392.51 | 505.27 | 460.35 | |
| Other line items | |||||
Quick Ratio |
13.80 | 14.33 | 13.72 | 11.44 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.54) | (0.44) | (0.62) | (0.65) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
2.27 | 4.70 | 4.27 | 4.74 | |
Average Assets |
474.43 | 470.50 | 515.84 | 482.92 | |
Average Common Equity |
456.17 | 446.66 | 486.46 | 451.98 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates